Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc.（AMPE）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AMPE · 截至 2026年6月9日
活动摘要
买入笔数
8
P-Purchase only
卖出笔数
7
近12个月
买卖比
1.14
Buy/Sell (by trades)
整体情绪
Ampio Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
AMPE 季度内部人买卖趋势
AMPE 内幕交易卖出 · AMPE 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
AMPE 高管卖出股份 · AMPE 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 9, 2023 | BUCHI J KEVIN Director | Purchase | 21,858 | $6K | Form 4 |
| Jun 8, 2023 | BUCHI J KEVIN Director | Purchase | 25,000 | $7K | Form 4 |
| May 24, 2023 | MARTINO MICHAEL A CEO · Director | Purchase | 76,890 | $22K | Form 4 |
| May 16, 2023 | BUCHI J KEVIN Director | Purchase | 32,534 | $9K | Form 4 |
| May 15, 2023 | BUCHI J KEVIN Director | Purchase | 44,026 | $11K | Form 4 |
| May 12, 2023 | BUCHI J KEVIN Director | Purchase | 23,440 | $6K | Form 4 |
| May 12, 2023 | Stevens David R Director | Purchase | 45,000 | $10K | Form 4 |
| May 11, 2023 | Stevens David R Director | Purchase | 25,000 | $5K | Form 4 |
| May 11, 2023 | Stevens David R Director | Purchase | 25,000 | $6K | Form 4 |
| Jan 1, 2022 | STOKELY DAN CFO | Other | 22,914 | $13K | Form 4 |
| Jan 1, 2022 | Cherevka Holli PRESIDENT AND COO | Other | 47,200 | $27K | Form 4 |
| Jan 1, 2022 | MACALUSO MICHAEL Director | Other | 68,400 | $39K | Form 4 |
| Oct 27, 2021 | STOKELY DAN CFO | Other | 28,127 | $46K | Form 4 |
| Oct 27, 2021 | Cherevka Holli PRESIDENT AND COO | Other | 41,980 | $69K | Form 4 |
| Oct 27, 2021 | MACALUSO MICHAEL CEO · Director | Other | 43,470 | $71K | Form 4 |
| Oct 11, 2021 | MACALUSO MICHAEL CEO · Director | Award | 950,000 | — | Form 4 |
| Oct 11, 2021 | STOKELY DAN CFO | Award | 335,000 | — | Form 4 |
| Oct 11, 2021 | Cherevka Holli CHIEF OPERATING OFFICER | Award | 500,000 | — | Form 4 |
| Jun 25, 2021 | STOKELY DAN CFO | Option | 22,500 | $10K | Form 4 |
| Jun 25, 2021 | STOKELY DAN CFO | Sale | 22,500 | $40K | Form 4 |
| May 21, 2021 | Cherevka Holli CHIEF OPERATING OFFICER | Option | 2,603 | $1K | Form 4 |
| May 21, 2021 | Cherevka Holli CHIEF OPERATING OFFICER | Sale | 2,603 | $5K | Form 4 |
| May 21, 2021 | COELHO PHILIP H Director | Option | 6,737 | $3K | Form 4 |
| May 21, 2021 | COELHO PHILIP H Director | Sale | 6,737 | $13K | Form 4 |
| May 17, 2021 | STOKELY DAN CFO | Option | 35,000 | $15K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AMPE 内幕交易
AMPE 内幕交易
Ampio Pharmaceuticals, Inc.（AMPE）内幕交易数据来源于公司内部人（包括AMPE）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。AMPE内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Ampio Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AMPE 内幕交易 · 5个问题Ampio Pharmaceuticals, Inc.（AMPE）的内部人包括高管和董事，如AMPE等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026